Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

KORU MEDICAL SYSTEMS, INC.

(KRMD)
  Rapport
Vertraagde tijd Nasdaq  -  15:32:02 30-01-2023
3.881 USD   -0.74%
25/01KORU Medical Systems, Inc. kondigt Subcutane Immunoglobuline voorgevulde spuit ontwikkelingsovereenkomst aan
CI
06/01KORU Medical Systems, Inc. : Piper Sandler handhaaft koopadvies
MM
2022KORU Medical Systems, Inc. : Canaccord Genuity verhoogt advies van Neutraal naar Kopen
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op KORU MEDICAL SYSTEMS, INC.
25/01KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Developmen..
25/01KORU Medical Systems, Inc. Announces Subcutaneous Immunoglobulin Prefilled Syringe Deve..
2022KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Confere..
2022KORU Medical Systems to Participate in Upcoming Investor Conferences
2022Part i - item 2. management's discussion and analysis of financial condition and resul..
2022KORU Medical Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
2022Koru Medical : Presentation Q3 2022
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q3 Revenue $7.8M, vs. Street Est of ..
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Loss $-0.03, vs. Street Est of $-0...
2022KORU Medical Systems Announces 2022 Third Quarter Financial Results
2022KORU Medical Revised Revenue Guidance for the Full Year of 2022
2022KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with K..
2022KORU Medical Systems, Inc. Announces Novel Therapy Collaboration for Three Indications ..
2022KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022
2022KORU Medical Systems to Participate in Upcoming Industry Conferences
2022KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
2022KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
2022KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped fr..
2022Part i - item 2. management's discussion and analysis of financial condition and resul..
2022KORU Medical Systems, Inc. Reports Earnings Results for the Second Quarter and Six Mont..
2022Koru Medical : Announces 2022 Second Quarter Financial Results - Form 8-K
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q2 Revenue $6.5M
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q2 Loss $-0.06
2022KORU Medical Systems Announces 2022 Second Quarter Financial Results
2022KORU Medical Systems, Inc. Revises Earnings Guidance for the Full Year 2022
2022KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022
2022Koru Medical Systems, Inc. : Entry into a Material Definitive Agreement, Creation of a Dir..
2022Koru Medical Systems, Inc. Enters into A Loan Modification Extension Agreement with Key..
2022Koru Medical Systems, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Ye..
2022Repro Med Systems Inc : Entry into a Material Definitive Agreement, Change in Directors or..
2022Repro Med Systems, Inc. Announces Chief Financial Officer Changes
2022Repro Med Systems Inc : Submission of Matters to a Vote of Security Holders (form 8-K)
2022Part i - item 2. management's discussion and analysis of financial condition and resul..
2022Repro Med Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $6.2M, vs. Street Est of $6..
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Loss $-0.05, vs. Street Est of $-0...
2022KORU Medical Systems Announces 2022 First Quarter Financial Results
2022KORU Medical Systems Revises Earnings Guidance for the Year 2022
2022KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELIģ (pegcetaco..
2022KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022
2022Koru Medical Systems Names Brian Case Chief Technology Officer
2022KORU Medical Systems Appoints Brian Case As Chief Technology Officer
2022Repro Med Systems, Inc. Appoints Brian Case as Chief Technology Officer
2022Repro Med : KORU MEDICAL SYSTEMS ANNOUNCES 2021 Q4 AND FULL YEAR FINANCIAL RESULTS - Form ..
2022Repro Med : Presentation FY 2021
2022REPRO MED SYSTEMS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
2022KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Loss $-0.02, vs. Street Est of $-..
2022Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q4 Revenue $6.5M, vs. Street Est of $6..
2022Repro Med Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2..
2022Tranche Update on Repro Med Systems, Inc.'s Equity Buyback Plan announced on November 1..
2022Repro Med Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December ..
2022Repro Med Systems, Inc. Provides Revenue Guidance for the Fiscal Year 2022
2022Earnings Reaction History: Repro-med Systems, 100.0% Follow-Th..
2022CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 20..
2021Repro Med Systems, Inc.'s Equity Buyback announced on November 16, 2020, has expired wi..
2021Repro Med Systems Gets US FDA 510(k) Clearance for Freedom60 With Two Additional Subcut..
2021KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60ģ with T..
2021KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60ģ with T..
2021Repro Med : Regulation FD Disclosure - Form 8-K
2021Repro Med Systems Inc : Regulation FD Disclosure (form 8-K)
2021Repro Med : KORU Medical Investor Day Presentation
2021Repro Med : KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day - Form 8..
2021Repro Med Systems Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
2021KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day
2021Repro Med : Q3 Canaccord Conference Presentation
2021Repro Med : Q3 Craig-Hallum Conference Presentation
2021Repro Med Systems Shares Climb After Securing 510k Clearance For FreedomEdge Infusion P..
2021Part i - item 2. management's discussion and analysis of financial condition and resul..
2021Tranche Update on Repro Med Systems, Inc.'s Equity Buyback Plan announced on November 1..
2021Repro Med Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
2021KORU MEDICAL SYSTEMS ANNOUNCES 2021 THIRD QUARTER FINANCIAL RESULTS - Form 8-K
2021Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $6M, vs. Street Est of $5.4..
2021Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q3 Loss $-0.02, vs. Street Est of $-..
2021KORU Medical Systems Announces 2021 Third Quarter Financial Results
2021KORU Medical Announces FDA Clearance for Delivery of Hizentraģ Prefilled Syringes
2021Repro Med Systems, Inc. Announces FDA Clearance for Delivery of Hizentra? Prefilled Syr..
2021KORU Medical Systems to Participate in Two Upcoming Conferences
2021KORU Medical Announces Collaboration With Gilero to Accelerate Innovation
2021KORU Medical Expands Senior Team to Accelerate Growth Strategy
2021KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 202..
2021KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulator..
2021Repro Med : Q2 2021 Canaccord Conference Presentation
2021Repro Med : KORU Medical Systems Announces 2021 Second Quarter Financial Results (Form 8-K..
2021Repro Med : Part i - item 2. management's discussion and analysis of financial condition a..
2021Tranche Update on Repro Med Systems, Inc.'s Equity Buyback Plan announced on November 1..
2021Repro Med Systems, Inc. Reports Earnings Results for the Second Quarter Ended June 30, ..
2021Repro Med : Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q2 Revenue $5.5M,..
2021Repro Med : Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q2 Loss $-0.02,..
2021Koru Medical Systems : Announces 2021 Second Quarter Financial Results
2021Koru Medical Systems : to Participate in Canaccord Genuity's 41st Annual Growth Conference
2021Koru Medical Systems : to Report Second Quarter 2021 Financial Results on August 11, 2021
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
2021Repro Med Systems, Inc.(NasdaqCM:KRMD) dropped from Rus..
Volgende evenement op KORU MEDICAL SYSTEMS, INC.